BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32777069)

  • 1. Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease.
    Kucukal E; Man Y; Quinn E; Tewari N; An R; Ilich A; Key NS; Little JA; Gurkan UA
    Blood Adv; 2020 Aug; 4(15):3688-3698. PubMed ID: 32777069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM.
    Zhang J; Abiraman K; Jones SM; Lykotrafitis G; Andemariam B
    Biophys J; 2017 Jan; 112(1):143-152. PubMed ID: 28076805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.
    Alapan Y; Kim C; Adhikari A; Gray KE; Gurkan-Cavusoglu E; Little JA; Gurkan UA
    Transl Res; 2016 Jul; 173():74-91.e8. PubMed ID: 27063958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.
    Liu Y; Zhong H; Bao W; Mendelson A; An X; Shi P; Chou ST; Manwani D; Yazdanbakhsh K
    Blood; 2019 Aug; 134(7):579-590. PubMed ID: 31076443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.
    Zennadi R; Whalen EJ; Soderblom EJ; Alexander SC; Thompson JW; Dubois LG; Moseley MA; Telen MJ
    Blood; 2012 Feb; 119(5):1217-27. PubMed ID: 22147898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease.
    Kucukal E; Man Y; Hill A; Liu S; Bode A; An R; Kadambi J; Little JA; Gurkan UA
    Am J Hematol; 2020 Nov; 95(11):1246-1256. PubMed ID: 32656816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease.
    Setty BN; Stuart MJ
    Blood; 1996 Sep; 88(6):2311-20. PubMed ID: 8822953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells.
    Shiu YT; Udden MM; McIntire LV
    Blood; 2000 May; 95(10):3232-41. PubMed ID: 10807794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.
    Zennadi R; Moeller BJ; Whalen EJ; Batchvarova M; Xu K; Shan S; Delahunty M; Dewhirst MW; Telen MJ
    Blood; 2007 Oct; 110(7):2708-17. PubMed ID: 17609430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Sickle Red Blood Cell Adhesion and its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative.
    Alshaiban A; Muralidharan-Chari V; Nepo A; Mousa SA
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):230-8. PubMed ID: 25601897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation.
    Kaul DK; Liu XD; Zhang X; Mankelow T; Parsons S; Spring F; An X; Mohandas N; Anstee D; Chasis JA
    Am J Physiol Cell Physiol; 2006 Nov; 291(5):C922-30. PubMed ID: 16738001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease.
    Barabino GA; McIntire LV; Eskin SG; Sears DA; Udden M
    Prog Clin Biol Res; 1987; 240():113-27. PubMed ID: 3615482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.
    Wulftange WJ; Kucukal E; Man Y; An R; Monchamp K; Sevrain CD; Dashora HR; Owusu-Ansah AT; Bode A; Ilich A; Little JA; Key NS; Gurkan UA
    Br J Haematol; 2022 Sep; 198(5):893-902. PubMed ID: 35822297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priapism, hemoglobin desaturation, and red blood cell adhesion in men with sickle cell anemia.
    Yuan C; Quinn E; Kucukal E; Kapoor S; Gurkan UA; Little JA
    Blood Cells Mol Dis; 2019 Nov; 79():102350. PubMed ID: 31404907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
    An R; Man Y; Cheng K; Zhang T; Chen C; Wang F; Abdulla F; Kucukal E; Wulftange WJ; Goreke U; Bode A; Nayak LV; Vercellotti GM; Belcher JD; Little JA; Gurkan UA
    Br J Haematol; 2023 May; 201(3):552-563. PubMed ID: 36604837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction.
    Nader E; Conran N; Romana M; Connes P
    Compr Physiol; 2021 Apr; 11(2):1785-1803. PubMed ID: 33792905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells.
    Zhang J; Jones SM; Lykotrafitis G; Andemariam B
    PLoS One; 2019; 14(5):e0216467. PubMed ID: 31083675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress activates red cell adhesion to laminin in sickle cell disease.
    Lizarralde-Iragorri MA; Lefevre SD; Cochet S; El Hoss S; Brousse V; Filipe A; Dussiot M; Azouzi S; Le Van Kim C; Rodrigues-Lima F; Français O; Le Pioufle B; Klei T; van Bruggen R; El Nemer W
    Haematologica; 2021 Sep; 106(9):2478-2488. PubMed ID: 32855277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.